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ABSTRACT. Increasing interest has been paid to label-free biosensors in recent years. 11 
Among them, refractive index (RI) optical biosensors enable high density and the chip-12 
scale integration of optical components. This makes them more appealing to help 13 
develop lab-on-a-chip devices. Today, many RI integrated optical (IO) devices are made 14 
using silicon-based materials. A key issue in their development is the 15 
biofunctionalization of sensing surfaces because they provide a specific, sensitive 16 
response to the analyte of interest. This review critically discusses the 17 
biofunctionalization procedures, assay formats and characterization techniques 18 
employed in setting up IO biosensors. In addition, it provides the most relevant results 19 
obtained from using these devices for real sample biosensing. Finally, an overview of 20 
the most promising future developments in the fields of chemical surface modification 21 
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1. Introduction. Approach to Refractive Index Optical BioSensors 41 
Nowadays, biosensing is a scientific and technological hot topic given its potential in 42 
fields such as medical diagnosis, healthcare, environment, defense and food security. In 43 
these realms, the specific and sensitive detection of targets in short-time analyses plays 44 
a primordial role.  45 
Traditionally, labeled formats have been used, where targets or reporter molecules 46 
carry fluorescent, enzymatic or radioactive tags. These techniques present high 47 
sensitivity, and even achieve single molecule detection [1], and are currently the 48 
standard techniques for many determinations. However, the development of label-free 49 
techniques has attracted the interest of many researchers over the last decade [2-6]. 50 
They offer advantages such as direct detection, real-time monitoring, kinetic 51 
information, fewer reagent costs, and the native molecular conformation of the protein 52 
is not altered by a tag. Thus, label-free biosensors based on optical [7], electrical [8-13] 53 
and mechanical principles [14-18] can be found. Optical sensors are more versatile than 54 
others because they can be made from different materials, such as silicon, glass, metals 55 
or polymers, and they offer different detection modes and architectures that can be 56 
combined [19]. They also offer other advantages; mass-scale fabrication, excellent 57 
physical properties, good selectivity and sensitivity; and can accomplish multiplexed 58 
detection in a single device [20,21]. Label-free optical biosensors have received 59 
increasing attention and many reviews can be found that provide a general overview of 60 
the state of the art [22-25]. In label-free optical detection, the transduction mode may be 61 
based on the refractive index (RI), optical absorption or Raman spectroscopy [26-30]. In 62 
past two decades, optical sensors based on refractive index (RI) changes feature among 63 
the most studied (Figure 1).  64 
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In ordinary dielectric material, the refractive index (RI) directly relates to the 65 
polarizability of molecules at optical wavelengths. Biological molecules have a higher 66 
RI than air or water, and they lower the propagation speed of the electromagnetic fields 67 
passing through them. Optical biosensors are designed to translate changes in the 68 
propagation velocity of light through a medium that contains biological material into a 69 
quantifiable signal proportional to the amount of material present on the sensor surface. 70 
For this reason, the electromagnetic field bound to an optical device that couples some 71 
energy to an external medium (called an evanescent field) penetrates a few hundred 72 
nanometers into the optically rarer environment from the optically denser guiding 73 
medium.  74 
Different optical phenomena have been employed to design RI optical biosensors. 75 
Representative methods include: Surface Plasmon Resonance [31,32], Reflectometric 76 
Interference Spectroscopy [33,34], Dual polarization Interferometry [35,36], Photonic 77 
Crystal Technology [37,38], and Whispering Gallery Mode Resonators [39,40]. 78 
Extensive reviews have been written and detail all these approaches which have 79 
developed to act as biosensors [25, 39, 40, 41].  80 
The search for analytical platforms that operate rapidly and efficiently has received 81 
increasing interest in recent years, not only for RI optical biosensors in particular, but 82 
also for label-free biosensors in general [42,43]. Optical label-free biosensors are ideal 83 
candidates for lab-on-a-chip (LOC) applications [41,44,45] as they allow the integration 84 
of both fluidic handling and optical analyses into a single chip. These integrated sensing 85 
devices enable the mass production of high-density biosensors, and provide rapid, 86 
sensitive and multiplexed measurements at the required point. Integrated Optical (IO) 87 
Biosensors employ guided waves or modes in planar optical waveguides. Besides 88 
Silicon-on-Insulator (SOI) technology, waveguide materials usually include high 89 
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refractivity silicon dioxide or titanium dioxide and silicon nitride films in oxidized 90 
silicon wafer substrates. 91 
A number of different IO biosensors has been designed and significant advances have 92 
been made in label-free interferometric [46], grating-coupled [47,48], photonic crystals 93 
[37,38,39] and microcavity resonators [39,40,49-52] biosensors. 94 
Within waveguiding interferometers, Mach-Zehnder [44,53-55], and in a less extent 95 
Young interferometers [56,57] are used mainly for biosensing, although novel 96 
interferometric designs with improved performance are being continuously explored 97 
[58-60].  98 
The materials used to construct integrated interferometers for biosensing include 99 
mainly silicon oxide, silicon nitride, SOI and, to a lesser extent, polymers. 100 
Grating coupled sensors are made from SiO2, Ta2O5 and SiO2/TiO2 on glass 101 
substrates, and they rely on the phenomenon that the coupling of light of a certain 102 
wavelength into a planar optical waveguide via grating occurs only at a critical 103 
incidence angle. The measurement principle can be Optical Waveguide Lightmode 104 
Spectroscopy (OWLS) [47] or Wavelength Interrogated Optical Systems (WIOS) 105 
[61,62]. 106 
Photonic crystals (PhC) are dielectric structures whose periodicity is in the order of a 107 
wavelength. The frequency of light that is coupled into PhC depends on the RI in the 108 
local environment around an introduced defect, which acts as a transduction signal 109 
when biorecognition takes place [63]. In other designs [38,64], binding events shift the 110 
wavelength of the reflected light proportionally to the adsorbed mass.  111 
Another emerging class of miniaturized optical resonators, which reach exceptionally 112 
high-quality Q-factors, are the Whispering Gallery Mode resonators [65]. To date, they 113 
have been implemented into three major configurations: microfabricated rings, disks 114 
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and toroids [39,41], stand-alone microspheres [66,67], and capillary-based optofluidic 115 
ring resonators (OFRs) [68]. Among them, silica micro disks, rings and toroids are 116 
preferred for IO devices. 117 
An excellent overview on the recent developments in resonant microcavities and 118 
photonic crystals for chemical and biological analysis was recently published by 119 
Luchansky and Bailey [39]. 120 
Other highly sensitive label-free biosensors based on optical fibers also exist [69]. 121 
However, they need external optical components that are not integrated into the chip, as 122 
well as larger sample volumes. Therefore, miniaturized optical devices are preferred for 123 
portable applications that also include LOC architectures. 124 
Two points are key to construct IO biosensors: optofluidic integration [25,39,41,70-125 
72] and device biofunctionalization. Regarding functionalization, and although 126 
everyone agrees on the importance of proper surface functionalization to provide 127 
selectivity and good sensitivity, systematic studies into the biofunctionalization 128 
processes employed in these devices are lacking. Such methodologies are generally 129 
based on the same principle, but there is disagreement about procedures, and treated 130 
surfaces are often poorly characterized. Because silicon technology appears to be the 131 
choice currently preferred for the majority of IO biosensors, the biofunctionalization 132 
chemistries employed in the sensors constructed on silicon-based materials are 133 
discussed in the next section.  134 
Surface modification of planar silicon-based substrates, with covalently linked 135 
organic monolayers, has been extensively studied [73-76]. In addition, the literature 136 
describes organic surface modification of silicon nanowires for sensing [77,78]. 137 
This review is an overview of all the different surface modification strategies 138 
explored to functionalize Si-based IO biosensors, and it discusses the bioreceptors and 139 
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methodologies employed, the techniques available for surface characterization, and the 140 




2. Surface Chemistry Approaches for Bioreceptor Attachment on Silicon-Based 143 
Materials 144 
2.1. Chemical Surface Modifications and Bioreceptors Attachment 145 
The specific detection of analytes is based on the immobilization of a bioreceptor that 146 
interacts with the target of interest. Immobilization can be done in two ways: direct 147 
adsorption; covalent, electrostatic or affinity binding. In all cases, it is necessary to 148 
modify the surface of the support material to the extent that the material properties are 149 
tuned to accomplish the best analytical characteristics. Performance comprises: favoring 150 
the receptor attachment that induces selectivity to a target of interest; preventing surface 151 
fouling; changing the hydrophobicity/hydrophilicity of the surface, while maintaining 152 
the sensing system’s physical (optical, mechanical, etc.) properties.  153 
Although bioreceptor physisorption has been widely used, especially for the 154 
preliminary demonstrations of new optical sensors designs 
 
[79-87], it has several 155 
drawbacks, which include: random orientation, lack of reproducibility, long incubation 156 
times, and risk of folding and desorption when the receptor is adsorbed. This issue is 157 
very important when working in flow and when chip regeneration is desired. In such 158 
cases, the covalent attachment of receptors is recommended. 159 
Ideally, biofunctionalization chemistries should fit the following requirements: gentle 160 
enough to avoid the structural damage of both the receptor and the transducer; few 161 
reaction steps; low optical adsorption at the working wavelengths; homogeneously thin 162 
layer formation that is compatible with evanescent field sensing; good surface coverage; 163 
reproducibility; robustness; low non specific binding; minimal sample and reagents 164 
consumption; easy handling; biocompatible conditions (pH, ionic strength, solvent, 165 
etc.); integrability with mass-scale fabrication. 166 
9 
 
Selecting a proper immobilization technique is a key point as many factors can 167 
negatively affect final biosensor performance. Several aspects, such as orientation and 168 
probe density on the surface, pH, target concentration, matrix effects, operating 169 
conditions and impact of the targeting strategy on transducer sensitivity, must be 170 
carefully analyzed. 171 
Figure 2 represents the main functionalization approaches employed to construct IO 172 
biosensors.  173 
2.1.1. Chemical Surface Modification by Self-Assembled Silane-Based Layers 174 
Most of the methods applied to functionalize silicon surfaces employ the self-175 
assembly of organofunctional alkoxysilanes (Figure 2a). This strategy assumes standard 176 
glass-based surface functionalization chemistry, and is well-suited to the 177 
functionalization of silica-on-silicon optical devices. The reaction is based on the 178 
condensation between the siloxanes of the organosilane and hydroxyl moieties present 179 
on the surface. Thus, the density of silanol groups is a determinant to form a proper 180 
organic layer. In the case of silicon and silicon nitride materials, the hydroxyl groups 181 
derive from the native silicon oxide layer, which is always present, although etching the 182 
native layer and forming a new one, usually by thermal oxidation, is commonplace [88-183 
92].  184 
The formation of silane self-assembled monolayers (SAMs) is more complex than the 185 
assembly of thiol molecules on gold surfaces. Yet it offers one important advantage in 186 
that silane-terminated monolayers show higher physical and chemical stability as 187 
opposed to thiol-ended ones. Therefore, it is possible to apply a large pool of chemical 188 
reactions. Alkylsiloxane monolayers are usually prepared by a chemisorption process of 189 
self-assembling molecules, such as trichloro-, trimethoxy- or triethoxysilanes, onto the 190 
solid substrate [93]. Despite the formation mechanism having been extensively 191 
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investigated, there is still some controversy [94-95]. It is well-known that certain 192 
parameters, such as water content, solvent use, age of the solution, deposition time and 193 
temperature, are still largely depended on [96]. In our opinion, not enough attention is 194 
paid to these issues. Frequently, the reaction conditions are established randomly, as 195 
evidenced by the fact that different concentrations, solvents (from aqueous ethanol to 196 
anhydrous toluene), reaction times or temperatures are employed for the same 197 
organosilane, by assuming that a monolayer is formed. 198 
Immediately before silanization, surfaces are cleaned with oxidant media to remove 199 
organic pollutants and to increase the hydroxyl moieties on the surface (≈1015 per cm2) 200 
[73]. A cleaning process to generate reactive hydroxyl groups is critical for the effective 201 
immobilization of silanes. There are several types of Si-OH groups that can be formed 202 
on silica surfaces. Some (germinal and isolated silanols) are reactive, whereas others 203 
(the vicinal silanol and siloxane groups) are not. The most widely used oxidants are 204 
oxygen plasma [97-103] and piranha solution [63, 104-111], consisting of a 205 
concentrated sulfuric acid: a hydrogen peroxide mixture at different ratios varying from 206 
3:1 to 7:3. This treatment is well-performed at room temperature or by heating, but 207 
usually for only a few minutes. The literature also describes other oxidants and cleaning 208 
agents comprising ozone-UV [112], sodium hydroxide [113], the ammonia:hydrogen 209 
peroxide mixture [114,115], nitric acid [53,116], hydrochloric acid [117], sulfuric acid 210 
[118], chromic acid [119], or mineral acids with hydrogen peroxide [115]. Sometimes 211 
more than one of these treatments is combined and sequentially applied to the chip 212 
[115,117,120,121]. 213 
Our group compared the two mostly used oxidation protocols -oxygen plasma and 214 
piranha treatment- using planar silica chips. In both cases, the water contact angle 215 
became 0º after the oxidation step (36º before oxidation), indicating the large number of 216 
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hydroxyl groups created on the surface. Afterward, the organosilane layer formed using 217 
3-aminopropyltriethoxysilane (APTES) provided similar results for both procedures. 218 
Piranha solution was also used to regenerate the surface. However, our experience 219 
indicates that the best procedure must be evaluated in each case; thus, we found the 220 
piranha treatment was the most suitable for silicon and silicon nitride materials, while a 221 
chromic mixture was the best choice for silicon oxynitride surfaces. Furthermore, the 222 
number of feasible regenerations on the same surface is limited and has to be evaluated 223 
experimentally. Our studies have found that the number of regeneration cycles ranges 224 
from three to five. 225 
Among the vast variety of commercially available organosilanes [122], very few have 226 
been used to functionalize IO transducers. In our opinion, there are two reasons for this: 227 
first, short alkyl chains are preferred as the evanescent field decays with distance from 228 
the surface; second, the methods are adopted from the well-established glass-based 229 
bioconjugation methods employed in biochips. Thus, –NH2, -SH, -COOH, or epoxy 230 
functionalities, are mainly employed [123]. 231 
The methods applied for the biofunctionalization of silicon-based IO biosensors are 232 
discussed according to the terminal functionality of the organosilane used. The 233 
bioconjugation protocol following organosilane layer assembly is also critically 234 
presented. 235 
NH2 organosilane 236 
Given its reactivity to aldehyde, carboxylic acid and epoxy functionalities, APTES (3-237 
aminopropyltriethoxysilane) [53,63,89-92, 107-110,97, 100,103, 112, 238 
114,116,120,124,125-127] and APTMS (3-aminopropyltrimethoxysilane) 239 
[88,111,98,99,128] have become the most widely used linker compounds for 240 
biofunctionalization purposes (Figure 3). However, the conditions employed differ for 241 
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silane concentration, solvent and incubation time. Moreover, a curing process is often 242 
performed after silanization. The trimethoxy compound is more reactive and can be 243 
deposited on a substrate using 100% pure organic solvent. The advantage of this process 244 
is that a thinner, and a more controlled deposition of the silane, can be generated to 245 
create a monolayer of the aminopropyl groups on the surface. For triethoxysilane, the 246 
reaction must occur in the presence of water, otherwise the ethoxy groups are not 247 
reactive enough to spontaneously couple to the hydroxyl groups on the surface. 248 
Given the possibility of hydrogen bond formation between the amine of APTES and 249 
the SiOx surface, both the head and tail groups in the organosilane can be oriented 250 
toward the surface, which can result in a disordered layer [126]. Additionally, cross-251 
linking among alkoxysilane units may yield oligomerized silane structures, resulting in 252 
rough layers that are thicker than a monolayer. The optimal conditions for solvent-based 253 
silanization using APTES have been investigated on planar surfaces [96]. Experiments 254 
with a 1% APTES concentration provide good films where the reaction time was less 255 
than 1 h, and the APTES film becomes thicker with longer reaction times. 256 
Having aminated the surface, different procedures are employed to attach the probe. 257 
An aminated surface is used to directly immobilize antibodies by adsorption 258 
[53,125,127] or to covalently attach an N-hydroxysuccinimide ester-ended biotin (NHS-259 
bt) (Figure 3a) [88,97-100,103,110,111,112,114,116,128]. NHS esters bind in nearly 260 
quantitative yields with primary amines, resulting in the formation of a stable amide 261 
bond. However, NHS esters typically undergo rapid hydrolysis under aqueous 262 
conditions, and functional activity is compromised over time [129]. Hence the quality of 263 
the resulting biotinylated surface is highly dependent on the experimental conditions. 264 
Guo et al. [107] also employed NHS ester chemistry, but differently. An aminated 265 
surface is firstly carboxylated by treatment with succinic anhydride (Figure 3b). Then, 266 
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the active ester is formed with a mixture of 1-ethyl-3-(3-dimethylaminopropyl) 267 
carbodiimide (EDC) and NHS. Finally, the succinimide ester surface is used to couple 268 
amine-containing proteins, such as streptavidin and bovine serum albumin (BSA). 269 
Studies carried out in our lab employing the EDC/NHS conjugation of proteins on 270 
APTES-modified silicon oxide planar surfaces have shown that the active ester must be 271 
formed under well-controlled conditions; for instance, pH must be 3.5. High sensitivity 272 
to the experimental conditions implies that this approach lacks reproducibility and 273 
provides low yields of protein immobilization. Frequently, the protein remains on the 274 
surface after conventional washings due to passive adsorption. Therefore, assessing the 275 
covalent attachment of protein acidic washings is recommended.  276 
Aminosilane surfaces are also activated with homobifunctional crosslinkers like 1,4-277 
phenylenediisothiocyanate (1,4-PDI), which provide isocyanate groups that react with 278 
amine-ended oligonucleotide probes to form a thiourea bond (Figure 3c) [124]. 279 
However, the most widely used homobifunctional crosslinker is glutaraldehyde (Figure 280 
3d), employed to form an aldehyde-terminated surface which allows the reaction of 281 
amine groups by the formation of imines (Schiff bases). By this strategy, antibodies, 282 
BSA and amine-ended oligonucleotides have been attached to silicon IO devices 283 
[63,89,90,108,114]. Due to the reversibility of the imine bond, some authors have 284 
reported the use of a sodium cianoborohydride reduction step to obtain more stable 285 
amine bonds [89,108]. 286 
However, when we attempted this approach on silicon oxide planar surfaces, we 287 
observed that when working with a slightly basic pH (9-10), aldolic condensation takes 288 
place, providing a short polymer where aminated compounds are covalently attached by 289 
single bonds. Thus, reductive conditions are not required to accomplish stable bonds. 290 
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Another approach which proved robust, reproducible and very suitable for IO 291 
biosensors implementation is based on hydrazone bond formation using SoluLink 292 
chemistry (Figure 3e) [130,131]. It employs two crosslinkers; 6-hydrazinonicotinamide 293 
(S-HyNic) and succinimidyl-4-formylbenzamide (S-4FB); to covalently attach probes 294 
on aminated surfaces. This chemistry has been widely used in different configurations 295 
for the biofunctionalization of the silicon microring resonators [104,105,132-144] 296 
commercialized by Genalyte (to date, the only commercialized device dealing in 297 
nanophotonic based biosensing) [145]. 298 
After accomplishing surface amination with APTMS, 4-polyethylenglycol-4-299 
formylbenzoate (PEG-4FB) is added via succinamide coupling. The probe is previously 300 
reacted with a hydrazine nicotinoate (HyNic) moiety by also using succinamide 301 
chemistry. Then, a hydrazone bond takes place to covalently link the probe to the 302 
surface [132]. The inverse approach can also be used successfully by linking the 303 
hydrazine moiety to the surface and modifying the probe with S-4FB [105,133,134].  304 
Finally, in order to simplify the number of steps, an organosilane already bearing the 305 
HyNic moiety can also be employed to silanize the microring resonator surface 306 
[104,135,136,137,138,139,140,141,142,143,144]. 307 
SH organosilane 308 
Another approach that also leaves nucleophilic functionality on the surface involves 309 
the employment of a thiol-ended organosilane (Figure 4). 3-310 
mercaptopropyltriethoxysilane (MPTS) has been employed by Sepúlveda et al. [121] 311 
for the functionalization of an integrated Mach-Zehnder interferometer microsystem. 312 
This allows a thiolated oligonucleotide to be attached to the surface via disulfide bond 313 
linkage (Figure 4a). Thiol functionality also permits the attachment of probes through 314 
their amine groups using heterobifunctinal crosslinker m-maleimidobenzoyl-N-315 
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hydroxysuccinimide ester (MBS), as demonstrated by Xu et al. [119] in an 316 
implementation of a planar optical waveguide-based interferometer (Figure 4b). 317 
The employment of disulfide bonds to attach thiolated oligonucleotides on silanized 318 
surfaces offers the advantage of reusability. As the disulfide bond is reversible, the 319 
surface can be regenerated, for instance, by treatment with dithiothreitol (DTT). 320 
However, this fact has yet to be demonstrated on an IO device. 321 
Another interesting approach is that which utilizes the advantageous click chemistry 322 
reaction between thiol and alkene moieties (Figure 4c). Our group has demonstrated the 323 
biotinylation of silicon oxide surfaces by this principle to perform hybridization assays 324 
in a microarray format, which achieves good performance, and is presently being 325 
implemented into a ring resonator-based biosensor [146].    326 
Epoxy organosilane 327 
Epoxy chemistry is an alternative coupling system for biomolecule immobilization 328 
given its stability under aqueous conditions and its reactivity to several nucleophiles, 329 
such as amine and sulfhydryl groups [147,148]. Thus, surfaces that are covalently 330 
coated with 3-glycidoxypropyltrimethoxysilane (GOPTS) can be used to conjugate 331 
thiol-, amine- or hydroxyl-containing ligands (Figure 5). 332 
GOPTS has been employed to covalently attach antibodies and aminated 333 
oligonucleotides by an epoxide ring opening in an optical microring resonator by 334 
Ramachandran et al. (Figure 5a) [113]. Scheneider et al. [118] constructed an IO 335 
biosensor based on a Hartman interferometer, performed the oxidation of epoxy 336 
moieties to aldehyde groups with sodium periodate, and further proved attachment by 337 
reductive amination with sodium cianoborohydride (Figure 5b).  338 
In an alternative approach after GOPTS silanization, De Vos et al. [101,102] used a 339 
thin layer of poly (ethylene) glycol (PEG) to prevent non specific binding in a microring 340 
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resonator biosensor (avoidance of non specific adsorption is also a critical issue and is 341 
dealt with separately). Thus, two heterobifunctional PEGs are used: one bearing thiol 342 
and carboxylic acid moieties, and the other containing two amine functionalities, one of 343 
them with a protecting group. The use of such reagents allowed the introduction of 344 
reactive carboxyl and amino groups onto the surface of the SOI microring. Finally, 345 
biotinylation was carried out by EDC/NHS and NH2-biotin in the first case, and by 346 
NHS-biotin in the second [102,110]. Better performance was obtained with the second 347 
approach. For the protein attachment on aminated microring resonators, 348 
homobifunctional crosslinker di-succinimidyl carbonate (DSC) was also used. However 349 
this route proved less efficient than a NHS derivative [101].  350 
All the above-mentioned strategies take longer. Recently, we demonstrated the use of 351 
epoxy-ended surfaces for the direct attachment of the thiolated oligonucleotides induced 352 
by light (Figure 5c). The reaction times are thus cut to a few minutes if compared with 353 
the conventional nucleophilic attack of SH [149]. Nucleic acids hybridization assays in 354 
the microarray format reveal the potential of this approach which has been employed to 355 
develop a microring resonator-based biosensor showing high reproducibility, stability, 356 
selectivity and sensitivity to detect hybridized complementary strands with negligible 357 
unspecific adsorption (unpublished data).  358 
COOH organosilane 359 
Silane coupling agents containing carboxylate groups have also been utilized to 360 
functionalize IO devices with carboxylic acids for the subsequent conjugation with 361 
amine-containing molecules (Figure 6a) [58,117]. Duval et al. [58] employed 362 
carboxyethylsilanetriol sodium salt (CTES) on silicon nitride bimodal waveguide 363 
interferometers, and proteins were conjugated to the surface by EDC/NHS. A PhC 364 
microcavity sensor was carboxylated by Zlatanovic et al. [117] using an effective 365 
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chelator of metal ions, such as N-(trimethoxysilylpropyl) ethylene-diamine triacetic 366 
acid, while proteins were further conjugated by EDC/NHS. After organosilane layer 367 
formation, the remaining steps were performed online, and no data on yields or surface 368 
characterization are provided, except for the limit of detection for the biorecognition 369 
event. 370 
In addition, carboxylic acid-ended dimethyl monomethoxy organosilane has been 371 
used as a horizontal spacer to form mixed monolayers on a Mach-Zehnder 372 
interferometer by the co-adsorption of binary solutions containing both a carboxyl-373 
ended organosilane and another bearing biotin moiety [150]. However, there are no 374 
experimental details available on yields, conditions, etc. 375 
EDC/NHS-based chemistry for protein conjugation must be carefully carried out 376 
because reproducibility is highly dependent on the experimental conditions. Protein 377 
attachment to the carboxylated surface can be done in two ways. In a first approach, the 378 
active ester is formed on the surface using an acidic pH (3.5), and the protein is 379 
conjugated to the surface using a neutral pH (6.5). The second way involves the 380 
addition of EDC/NHS together with the protein (pH 6.5), and the conjugation is 381 
performed in one step; this case involves the risk of protein cross-conjugation, giving 382 
rise to aggregates. Besides in both cases, a risk of hydrolysis of the active ester must be 383 
taken into account, and control assays to demonstrate the covalent nature of the link 384 
between the protein and the surface are recommended (the protein can remain on the 385 
surface through the electrostatic interactions between the amine and the carboxylate 386 
moieties, without rendering the advantages of the covalent link). 387 
Isocyanate-ended organosilane 388 
Isocyanatepropyltriethoxysilane (ICPTS) has been used to link proteins onto silicon 389 
photonic crystals without crosslinkers or activation steps being needed [106,151]. The 390 
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isocyanate moiety reacts with amines to form isourea bonds, and with hydroxyl groups 391 
to form urethanes (Figure 6b). Oligonucleotides are also attached to the ICPTS surface 392 
using biotinylated probes which are affinity-captured by streptavidin covalently linked 393 
to the isocyanate modified surface [151]. This is a simple one-step approach, but the 394 
experimental conditions must be well-controlled to achieve an acceptable degree of 395 
reproducibility. Thus at a certain basic pH, there is a risk of decarboxylation, which 396 
provides an amine-ended surface instead of an isocyanate-ended one.   397 
It is noteworthy that organosilane-based chemistries are also being successfully 398 
applied to other integrated and non integrated optical label-free biosensors developed 399 
with different materials, such as glass microspheres [67] and liquid core optofluidic ring 400 
resonators [152,153], planar waveguides made of metal oxides, such as Ta2O5 [154,155] 401 
or SixTi(1-x)O2 -as in the commercialized OWLS system based on Optical Waveguide 402 
Lightmode Spectroscopy [156]-, and on the TiO2/SiO2 surfaces of polymeric PhC 403 
[19,157,158] commercialized as BIND™ Biosensor by SRU Biosystems [64]. 404 
Organosilane condensation on the silicon surface can be done by chemical vapor 405 
deposition (CVD) [53,97,100,106,111] or by wet chemistry [111,134]. A good 406 
comparison between CVD and wet chemistry was made by Hunt et al. [111] for the 407 
functionalization of silica microtoroids resonators with APTES, who indicated that 408 
chemical vapor deposition provides more ordered monolayers. 409 
2.1.2. Other Silicon Surface Chemical Modifications  410 
Although silane-based chemistry is the gold standard for the functionalization of 411 
silicon-based materials for sensor applications, the literature also describes other 412 
alternative surface derivatization approaches for IO biosensors development. 413 
Shang et al. [159] developed a conjugation strategy based on SAM formation with 414 
hydroxyl-ended organophosphonate (Figure 2b) based, in turn, on the “T-BAG” method 415 
19 
 
[160,161]. After SAM formation, divinylsulphone (DVS) was employed as a crosslinker 416 
to attach aminated glycanes [162]. Phosphonate chemistry has demonstrated good 417 
efficiency in the modification of a Silicon Nanowire-based DNA biosensor [163] and in 418 
SAM formation on SiO2 [164] or Ta2O5 [165]. This procedure is also the standard 419 
surface modification protocol for the fluorescence microarray chips commercialized by 420 
Zeptosens [166,167], made of Ta2O5 planar waveguides. 421 
Other strategies involve the derivatization of the silicon or silicon nitride by 422 
previously removing the native silicon oxide layer. Thus, porous silicon-based devices 423 
have been derivatized by hydrosilylation by reacting Si-H bonds with alkene moieties 424 
by thermal [168,169] or photochemical activation [170,171]. In this way, carboxylic 425 
acid-ended surfaces are obtained and used for aminated probe attaching by EDC/NHS. 426 
However, they are yet to be implemented in integrated optics due to long reaction times 427 
and the special reaction conditions required. In any case, the employment of 428 
photoinduced reactions, involving shorter times and better conditions, is an interesting 429 
idea to develop alternative functionalizations for IO devices. Our research group has 430 
derivatized silicon nitride with glutaraldehyde through surface N-H bonds after 431 
removing the silicon oxide native layer (Figure 2c). This allows the selective attachment 432 
of aminated probes against silicon oxide [172]. This approach was used for the 433 
biofunctionalization of a highly sensitive silicon nitride slot waveguide microring 434 
resonator [173], integrated with microfluidics, to perform excellent sensitivity [174]. 435 
Finally, other alternative approaches have also been explored by increasing probe 436 
loading on the surface while minimizing non specific binding. They are based on the 437 
use of dextran hydrogels or dendrimers. [175,176,177]. Thus Goddard et al. [175], after 438 
a functionalization of a 1D PhC surface with APTMS, used EDC/NHS and a carboxy-439 
terminated dendrimer to attach aminated oligonucleotides (Figure 2f). By utilizing a 440 
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biotinylated dextran hydrogel, Vollmer et al. [177] attached streptavidin-conjugated 441 
capture probes onto a silica microsphere cavity biosensor. Dextran-based 442 
biofunctionalization has also been applied to IO devices developed on other materials, 443 
such as Ta2O5 in a Waveguide Interrogated Optical Immunosensor (WIOS) [178].   444 
The main biofunctionalization approaches employed to date on IO biosensors are 445 
shown in Table S1 (Supplementary Material), and include reaction conditions, type of 446 
capture agent and biorecognition event. 447 
2.1.3. Capture Agents Employed as Model Systems 448 
Having performed chemical functionalization on the surface, different capture agents 449 
can be attached to the surface: biotin, proteins, antibodies, single-strand nucleic acids, 450 
aptamers and carbohydrates.  451 
This review classifies biosensors into two groups: those using a model system as 452 
proof-of-concept devices and employing capture agents toward targets of analytical 453 
interest, and even analyze real samples. The second group is discussed in more detail in 454 
Section 3 (Main Achievements). 455 
In proof-of-concept IO devices, two main model systems are used: a 456 
biotin/streptavidin pair (BT-STV) and a bovine serum albumin/anti bovine serum 457 
albumin pair (BSA/anti-BSA). BT-STV is used extensively thanks to its high affinity to 458 
recognition and its capacity to display oriented bioreceptors, and it is a well-459 
documented bioaffinity system [53, 97, 100-103,110,111,114,116,118,150]. 460 
Biotin is used in silicon-based IO biosensors in two ways. First, biotin is the capture 461 
agent used to detect streptavidin or avidin, and as a model system to demonstrate the 462 
fabricated device’s biosensing capability. Thus, avidin biosensing has been seen in IO 463 
ring resonators [101,102,110,120], and streptavidin has been used as a target for the 464 
biotinylated surfaces of microtoroid resonators [97,100,111], air slot silicon nitride 465 
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microdisk resonators [114], planar waveguides for Optical Waveguide Lightmode 466 
Spectroscopy (OWLS) [103], Mach-Zehnder interferometers [109,150] and ring 467 
resonators [116]. 468 
Second, a biotinylated surface is employed to immobilize a vast variety of biotin-469 
modified probe molecules according to the Avidin-Biotin Complexation (ABC) 470 
technique [179,180]. Following this approach, biotinylated Concanavalin A has been 471 
immobilized on silicon nitride sensing chips by Reflectometric Interference 472 
Spectroscopy [112]. Biotinylated antibodies have also been attached to porous silicon 473 
microcavity sensors [88,128], and biotinylated DNA has been employed as a capture 474 
agent linked to the surface of a silica microsphere cavity sensor [177]. 475 
In other devices, streptavidin, covalently attached to the surface, has been used to 476 
immobilize the biotinylated capture agent in an oriented fashion in order to perform real 477 
sample biosensing [107,108,118,132] (Section 3).  478 
The second model system is based on the BSA/anti-BSA (or HSA/anti-HSA) pair. 479 
Many studies into biosensing performances have been reported with these systems 480 
[84,86,87,102,106,173,174]. This is because BSA adsorbs very well onto the surface 481 
and surface functionalization is not absolutely necessary (if surface modification is 482 
done, no special care must be taken). BSA is adsorbed on SOI PhC [83,85] and is also 483 
covalently immobilized merely to demonstrate protein detection [91], and no further 484 
biorecognition event is performed. In other cases, BSA acts as a capture agent to 485 
monitor the recognition of its specific antibody (anti-BSA), as in a bimodal waveguide 486 
interferometer where BSA is adsorbed [84], and as a photonic crystal waveguide [106] 487 




Other uses of BSA have been presented in the literature. For instance, BSA has been 490 
used to carry other moieties responsible for target recognition; e.g., sugars [82] or biotin 491 
[117]. Similarly to the BSA/anti-BSA pair, human serum albumin (HSA) and its 492 
specific antibody (anti-HSA) have been employed to demonstrate biosensing in silicon 493 
nitride Mach-Zehnder interferometers [86,87] and in SOI microring resonators [101].  494 
Another pair employed as a model, be it to a lesser extent, is the binding IgG/anti-IgG 495 
pair where IgG antibodies are used as capture agents to recognize antiIgG 496 
[63,88,109,125,128]. 497 
When the sensor’s capability to detect hybridization events needs demonstrating, 498 
oligonucleotide probes ca be covalently attached to the surface. Generally, a synthetic 499 
fully complementary strand is used to perform hybridization event detection. Such 500 
experiments have been carried out on porous silicon-based optical devices [89, 90, 171], 501 
silicon nitride-based M-Z Interferometer [121] and SOI-based microring resonators 502 
[137,141]. Apart from these, very few examples using receptors other than the 503 
aforementioned ones are found in silicon-based IO devices [139,159].  504 
After bioreceptor attachment, a blocking step is often performed to avoid non specific 505 
binding, which can be achieved in two ways: using a blocking agent after bioreceptor 506 
attachment. Thus, BSA has been widely used for this purpose, especially when proteins 507 
or antibodies are employed as capture agents [88,107,113,134,135,136]. Commercial 508 
blocking buffers like Starting Block [118,137,140,143] PEG [101,115,118] and 509 
ovoalbumin protein (OVA) have also been employed. Generally in oligonucleotide 510 
probes, no blocking step with protein is required, although the chemical blocking of the 511 
remaining active sites is necessary. Thus, reducing agents [108] or ethanolamine 512 
[58,89,172] are/is used to block aldehyde, isocyanate and epoxy-ended surfaces after 513 
bioreceptor attachment. Second, designing surface functionalization chemistry helps 514 
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avoid biofouling, which is usually done with PEG derivatives [102,112,132] or 515 
dendrimers [177].  516 
Sometimes, a blocking step is not necessary as non specific binding is negligible 517 
[105,133,137]. Non specific binding depends not only on surface modification, but also 518 
on the fluidics and buffers employed during biorecognition. Thus, the optimization of 519 
such variables can lead to a specific recognition of analytes on unblocked surfaces.  520 
Comparing devices is difficult given lack of uniformity when optical biosensor 521 
sensitivity is given. So it is not infrequent that the target concentrations needed to 522 
distinguish the signal from noise background are very high, but much lower limits of 523 
detection from the interpolation in the saturation curve are reported. This is an important 524 
issue if the ultimate goal of the device is to act as a real sample biosensor. Table S2 525 
(Supplementary Material) presents the sensitivities or limits of detection reported for the 526 
IO devices discussed herein, comprising both the lowest target concentration applied to 527 
the chip and the reported sensitivity data. 528 
 2.2. Techniques Employed for the Biofunctionalization of IO Devices. 529 
From the biofunctionalization viewpoint, one important aspect is to place bioreceptors 530 
only in the device’s sensing area so that sensitivity remains undiminished. For the time 531 
being, this has been accomplished by chemically selective reactions [98,99,172] or by 532 
covering the chip with a protecting layer with open windows, but only in the sensing 533 
area. This also allows the selective functionalization of each device sensor with the 534 
various specific receptors to perform multiplex detection. 535 
The receptors are placed in the sensing zone by microspotting –either manually 536 
[102,105,133,137] or using a robotic spotter [82,109] – and by employing microfluidics 537 
[108,133,134,136,140,143,144]. Despite online functionalization being interesting in 538 
the initial stage when setting up and characterizing IO biosensors, it is not the best 539 
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option if chip fabrication is to be translated to a mass scale. This procedure is time-540 
consuming and presents other problems associated with the microfluidics, such as 541 
leaking, channel blocking, cross contamination, etc. 542 
2.3. Characterization Techniques for Modified Surfaces 543 
To check the success of the functionalization process, different characterization 544 
techniques are used. Figure 7 provides some examples of characterizations done on IO 545 
biosensors. As an initial stage, many researchers use planar substrates to perform the 546 
protocol. In general, characterization is accomplished in thickness by ellipsometry 547 
[101,109,111,114,172], in hydrophobicity by contact angle measurements 548 
[101,171,172], in chemical composition by XPS [98,101,111,115,159,172] and FT-IR 549 
spectroscopy [90,92,172], and in topography by AFM [98,115]. Fluorescence 550 
microscopy [92,101,114,172,177] and radio labeling [118,181] are also used to assess 551 
the bioconjugation of the receptor of interest. However, fluorescence labeling is not 552 
suitable when working with silicon surfaces due to this material’s quenching effect on 553 
tag emission [182]. This fact can be clearly observed in Figure 7a, where a microarray 554 
(3х1) of Cy5-labeled goat anti-rabbit antibody (5 ppm in PBS1x) is printed on the 555 
surface of Si, silicon nitride and SiO2 chips respectively, and fluorescence is read with a 556 
homemade surface fluorescence reader [183]. As seen, the fluorescence recorded for the 557 
silicon surface is considerably lower than that for silicon oxide. 558 
However, performances in planar sensors are not necessarily the same as on micro-559 
structured surfaces, and characterization techniques for nanostructures are also required. 560 
In general, fluorescence microscopy (Figure 7b) [82,98-100,111,172], SEM (Figure 7c) 561 
[97,99,113,172], and TOF-SIMs (Figure 7d) [159] have been used, but their 562 
applications are scarce.   563 
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Another possibility is to use the IO device to monitor the whole functionalization 564 
process step by step. For this purpose, microfluidics is used and success in the layer 565 
formation is related with the device’s RI response [58,104,133,137]. This is an 566 
interesting option when the material does not allow the use of fluorescence microscopy 567 
and techniques, like the SEM of TOF-SIMs, whose resolution is not sufficient to 568 
provide useful information. 569 
In conclusion, uniformity and rigor in the systematic characterization of the 570 
biofunctionalization process are lacking. In many studies, detection of the target analyte 571 
is considered sufficient and no further characterization is performed. In our opinion, 572 
knowing the functionalization characteristics allows process modifications that help 573 
improve the quality of intermediate layers, which will no doubt affect final biosensor 574 
performance. 575 
 576 
3. Performances and Applications. Main Achievements 577 
This section briefly describes the most interesting advances in IO devices for real 578 
sample biosensing. It is worth mentioning that almost all the significant developments 579 
made involve targets of clinical interest.  580 
The suitability of an optical biosensor for a particular application depends on its 581 
performance over a variety of metrics. This includes technical aspects, such as 582 
transducer sensitivity and bioassay sensitivity, as well as other parameters that evaluate 583 
market success possibilities (ease-of-use, sensor cost, portability, scalability and 584 
throughput).  585 
Transducer sensitivity is defined as variation in either the sensor output response 586 
resulting from a unit change refractive index (denominated bulk sensitivity) or the mass 587 
density (called surface sensitivity) on the sensor surface. It is independent of a 588 
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biofunctionalization process being performed and is used for sensor characterization at a 589 
basic level. However, the bioassay sensitivity must be measured to evaluate the device’s 590 
real biosensing capability and is the response variation to a given change in analyte 591 
concentration. It depends on both the biofunctionalization process and the affinity 592 
constant between receptor and analyte. Thus when working with the same optical 593 
device, high-molecular-weight molecules with a high affinity to the receptor are 594 
detected at lower concentrations than small molecules with a low binding affinity. It 595 
should be noted that the assay sensitivity value is mandatory if real biosensing is 596 
claimed. 597 
Table 1 summarizes the most relevant results obtained to date in real sample 598 
biosensing using IO devices. 599 
One platform demonstrating good performance for real sample biosensing is SOI 600 
microring resonators. Different assays have been performed in them using the 601 
hydrazine/aldehyde conjugation chemistry. By employing aminated DNA 602 
oligonucleotide probes attached to the surface, closely related bacterial species (S. 603 
neumoniae and S. agalacticae) are distinguished by monitoring specific probe 604 
hybridization with microRNAs (mRNAs) in a single, multiplexed assay; the smallest 605 
mRNA amount detected is 53 fmol [105]. This method has proven reproducible, and 606 
dehybridization with RNase enzyme enables sensor surface regeneration [133]. 607 
Sensitivity is improved by amplification using anti-DNA:RNA antibodies and by 608 
lowering the detected concentration to 350 amol (10 pM). With this device, the 609 
isothermal discrimination of DNA single nucleotide polymorphisms (SNPs) is achieved 610 
[137], and DNA-encoded antibodies against prostate specific antigen (PSA) and -611 
fetoprotein (AFP) are used to demonstrate the multiplex screening of capture agent 612 
binding properties [138,143]. The DNA encoding strategy consists in a self-assembly 613 
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process where antibodies are previously conjugated to specific sequences that are 614 
complementary to the DNA strands immobilized on the surface. It has an advantage 615 
over direct antibody covalent immobilization, that of improving its binding capacity (as 616 
it is oriented). Surface regeneration by a dehybridization step is also possible. 617 
Antibodies are also covalently attached to the surface to perform quantitative, 618 
multiplexed analyses of clinically relevant protein biomarkers: PSA, AFP, 619 
carcinoembryonic antigen (CEA), tumor necrosis factor-(TNF-) and interleukin-8 620 
(IL-8) by direct immunoassays [134,144]. Covalently linked antibodies are also used for 621 
the quantitation of biomarker C-reactive protein (CRP) in human serum and plasma 622 
directly and by a sandwich immunoassay, followed by a bead-enhanced third binding 623 
event to increase sensitivity [142]. Other interesting applications of such IO devices 624 
include: the specific, quantitative, multiplexed cytokine analysis of T-cell secretion by a 625 
one-step sandwich immunoassay [136,140], the multiplex binding kinetics 626 
determination of thrombin-binding DNA aptamer and anti-thrombin monoclonal 627 
antibody [139], or the quantitative detection of Bean pod mottle virus from leaf samples 628 
by direct immunoassay, involving quicker sample preparation and with a limit of 629 
detection of 10 ng mL
-1
 [135]. Carbohydrate-protein and norovirus particle interactions 630 
are characterized by the same microring resonator sensor array and organophosphonate 631 
based chemistry [159]. However, the results reported when this approach was adopted 632 
are preliminary, and the established and widely demonstrated methodology to 633 
functionalize microring resonators is that based on hydrazine-aldehyde conjugation. 634 
Vertically coupled high refractive index microring resonators show the specific 635 
capture of whole bacteria cell E. coli O157:H7 by direct immunoassay after the covalent 636 
immobilization of the specific monoclonal antibody using GOPTS [113]. Although 637 
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control assays do not reveal the covalent nature of antibody attachment in this case, 638 
bacteria recognition proves specific. 639 
By utilizing an integrated innovative bimodal waveguide interferometer, Duval et al. 640 
[58] recently demonstrated the picomolar detection level of human hormone hTSH by 641 
an indirect competitive immunoassay. In this case, carboxy-ended organosilane is used 642 
to functionalize the surface; while the hormone (antigen) is attached to the sensor 643 
through amine groups using EDC/NHS (no details of surface chemistry and 644 
characterization are provided). The specific antibody to hTSH is recognized by the 645 
receptor on the surface in an inversely proportional manner to the amount of hormone 646 
present in the sample. These methods are sensitive (20 pM), reproducible and specific. 647 
With a Mach-Zehnder interferometer design with planar optical waveguides, Xu et al. 648 
[119] also specifically recognized three avian influenza virus subtypes by direct 649 
immunoassay, with limits of detection of 5·10
-4
 hemagglutination units per milliliter 650 
(HA units mL
-1
). In this case, SH-ended organosilane is used and specific antibodies are 651 
attached to the surface by a 1-hour incubation with m-Maleimidobenzoyl-N-652 
hydroxysuccinimide ester as the crosslinker. Stability under storage at 4 ºC for several 653 
days is demonstrated. 654 
Ymeti et al. [56] used a four-channel integrated Young interferometer for the 655 
detection of herpes simplex virus type 1 (HSV-1) by a direct immunoassay with 656 
monoclonal specific antibodies immobilized on the surface via protein A in an oriented 657 
fashion. The whole process is developed online by monitoring real-time surface 658 
changes. Two points of this demonstrator must be highlighted; first, the specificity of 659 
the recognition is assessed by immobilizing different receptor layers in adjacent 660 
measuring channels and by monitoring the sensor response to different analyte 661 
solutions. Second, although protein A is adsorbed on the surface, negligible desorption 662 
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is noted for the analysis time, as observed from the baseline. Finally, solutions are 663 
allowed to flow over the sensor for no longer than 30 min, and very good results are 664 
obtained. Sensitivity is very high (850 particles mL
-1
) and the blood serum analysis is 665 
also reported, be it with lower sensitivity [81].  666 
Antibodies covalently attached on the surface of a Hartman interferometer-based 667 
optical chip have been reported by Schneider et al. [118] to detect human chorionic 668 
gonadotropin (hCG) in serum and whole blood. For this purpose, a sandwich 669 
immunoassay is performed using gold labeled secondary antibody to increase sensitivity 670 
(0.1 ng mL
-1
). Chemical surface functionalization is accomplished by silanization with 671 
GOPTS, followed by oxidative epoxy ring opening to provide an aldehydized surface. 672 
Then, avidin is attached to the surface by reductive amination and biotinylated-specific 673 
antibodies are bound to this surface. However, the most interesting point of this work is 674 
the study into non specific binding during measurements and how to compensate it 675 
using a reference channel. 676 
Qiao et al. [169] have demonstrated the first implementation of a porous silicon-based 677 
Bloch surface sensor for protease activity detection (7 g mL-1) based on the digestion 678 
of gelatin covalently attached to the surface. In this case, a hydrosilylation process is 679 
employed as the first modification step. This approach comprises many further steps, 680 
but sensitivity is poor; thus, it is not so interesting. 681 
Armani et al.
 
[184] have employed silicon-based microtoroids resonators to 682 
demonstrate real biosensing with extremely low sensitivities. To that end, protein G is 683 
adsorbed on the surface to bind by affinity-specific antibodies and to detect IL-2 in fetal 684 
bovine serum with a sensitivity close to a single molecule (5·10
-18
 M). PhC-based 685 
sensors have also demonstrated the capability of real biosensing. The so-called 686 
nanoscale optofluidic sensor array (NOSA) [185] has been used for the multiplex 687 
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detection of three interleukins (IL-4, IL-6, IL-8) by sandwich immunoassays. 688 
Streptavidin is covalently attached to the surface by using APTES and glutaraldehyde, 689 
which allow the oriented immobilization of biotinylated capture antibodies. Despite 690 
sensitivity not being that good (1 g mL-1), it is one of the first demonstrations of real 691 
multiplex biosensing with PhC [108]. With the same device and by also employing 692 
APTES and glutaraldehyde, four serotypes of Dengue virus were detected by 693 
immobilizing four specific DNA oligonucleotides and performing hybridization after 694 
adding the specific targets to the sensor [186].   695 
As seen, the sensor biofunctionalization conditions employed are diverse and vary in 696 
terms of assay times, blocking process, etc. To date, the most extensive, characterized 697 
work is that developed with microring resonators using hydrazine-aldehyde chemistry. 698 
A comparative study which adopts different approaches for the same sensor design and 699 
for the same bioassay is still lacking, along with any advances made in this research 700 
field. 701 
 702 
4. Future Trends 703 
One of the main advantages of IO technology is the possibility to integrate all 704 
functions (chemistry, optics, fluidics and electronics) into a single platform. Despite 705 
significant advances having been made in recent years toward developing IO biosensors 706 
capable of acting as point-of-care or lab-on-a-chip devices, several issues remain to be 707 
explored. The choice of the surface modification, biofunctionalization procedures, and 708 
the detection assay type and conditions, become a relevant issue to consider, together 709 
with the development and optimization of integrated optics-based sensing structures. 710 
Some interesting aspects to be studied in the future, which have the potential to improve 711 
already existing performance, are discussed in this section. 712 
31 
 
The effective and selective patterning for spatial control in the biofunctionalization of 713 
sensors to help accomplish high-density multiplexing has not yet been fully achieved. 714 
The use of automatic printers or microfluidic systems is a good option, but both 715 
techniques are quite time-consuming, and the search for easier and faster alternatives is 716 
an objective. In this sense, photoactivated coupling reactions, especially those in the 717 
click-chemistry group, have demonstrated their utility in planar platforms [146,187] and 718 
can be an interesting possibility to explore their application in the multiplex 719 
biofuncionalization of high-density array sensors.  720 
Moreover, new conjugation techniques that simplify the number of steps and place 721 
capture agents close to the surface in a bioavailable manner, while providing a robust 722 
and reproducible link, are another unexploited field of study. The analyses of next-723 
generation capture agents that improve the performance of those already in use are also 724 
desirable. 725 
Designing approaches that allow surface regeneration and provide versatility, as in the 726 
DNA-encoding strategy, should be one of the preferred options for new developments. 727 
There is a large number of novelties in relation to capture agents for real biosensing to 728 
be explored in the IO devices whose efficiency has been demonstrated on other assay 729 
platforms, such as the triplex affinity capture methods or use of synthetic (aptamers) or 730 
semi-synthetic molecules (peptide nucleic acids, PNA) as new probes [188-191]. 731 
Another highly desirable option is to find biofunctionalization strategies that are 732 
compatible with the manufacturing process of devices. This would make them mass 733 
production scalable, and would help them reach truly applicable point-of-need devices 734 
ready for end users. 735 
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Finally, the establishment of a testing model system would facilitate the comparison 736 
between devices. This system should include not only checking on specific binding, but 737 
also stability tests of functionalized devices for long-term storage. 738 
The issues discussed above rely only on the chemical functionalization of the surface 739 
and anchoring of bioreceptors. 740 
However, it is noteworthy that these developments have to be coupled with advances 741 
in other fields such as optics, fluidics and electronics. It is only in this way that real 742 
progress in the vast, multidisciplinary task of managing to manufacture RI integrated 743 
optical devices capable of providing fast, specific and sensitive responses at the point of 744 
need will be feasible. 745 
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Figure Captions 1108 
 1109 
Figure 1: Number of publications per year on the Refractive Index Optical BioSensing 1110 
topic during the last decade. 1111 
Figure 2: Scheme of the most relevant functionalization procedures on silicon-based 1112 
materials for IO biosensors: organosilane-based (a), phosphonate-based (b), and 1113 
glutaraldehyde-based (c) approaches. 1114 
Figure 3: Scheme of the bioconjugation procedures employed in IO biosensors for 1115 
aminated surfaces: N-hydroxysuccinimide-based (a), succinic anhydride-based (b), p-1116 
phenylenediisocyanate-based (c), glutaraldehyde-based (d) hydrazine-aldehyde-based 1117 
(e) and carboxy-ended dendrimer-based (f) approaches. 1118 
Figure 4: Scheme of the bioconjugation procedures employed in IO biosensors for 1119 
thiol-ended surfaces: disulfide bridge-based (a), m-maleimidobenzoyl-N-1120 
hydroxysuccinimide-based (b) and thiol-ended click chemistry-based (c) approaches. 1121 
Figure 5: Scheme of the bioconjugation procedures employed in IO biosensors for 1122 
epoxy-ended surfaces: nucleophilic ring opening-based (a), oxidative ring opening-1123 
based (b) and photo-induced ring opening-based (c) approaches. 1124 
Figure 6: Scheme of the bioconjugation procedures for the carboxylated surfaces (a) 1125 
and isocyanate-ended surfaces (b), employed in IO biosensors. 1126 
Figure 7: Some examples of IO biosensors characterizations: a) Comparison between 1127 
intensity of fluorescence in a microarray of a Cy5-labeled antibody (same 1128 
concentration) deposited onto a silicon (left) and a silicon oxide (right) surface; b) SEM 1129 
images of the slot waveguides with streptavidin selectively attached on silicon nitride 1130 
following the chemical approach shown in Figure 2.c; c) Fluorescence confocal 1131 
microscopy characterization for the SiN slot waveguides modified according to the 1132 
procedure shown in Figure 2c, and using the Cy5-labeled antibody and 1% Fluorescein 1133 
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isothiocyanate as a contrast; d) ToF-SIMS measurements (CN- and CNO- ions) on the 1134 
waveguides functionalized with isocyanate-ended organosilane (red arrows show the 1135 
defects on the organosilane layer formed on the surface), e) layout of an RI IO biosensor 1136 
consisting of seven slot waveguide ring resonators, six sensing rings and a reference 1137 
ring, a microscope image of a reference and a sensing ring (with an open window in the 1138 
sensing area) and a measurement scheme. 1139 
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